Are you an early stage researcher ready to write a new or revised NIH-style proposal and interested in receiving coaching support while you write? If so, we invite you to apply for participation in the University of Utah Grant Writing Coaching Research Study, funded by the NIH Common Fund (grant U01 GM132366; administered by the NIGMS). This study will compare variations of an established grant writing group coaching process to identify features that influence its effectiveness.
What is the Study About?
The University of Utah was awarded a grant from the National Institutes of Health (NIH) (grant #U01GM132366, IRB approval # 00113440) to study interventions aimed at refining the proposal writing skills of early stage investigators and increasing their success in receiving NIH grants. The interventions being tested are rooted in an intensive group coaching model for investigators who are actively writing, or poised to begin writing, a research grant application. The study will compare variations of the group coaching intervention to identify features that influence its effectiveness.
Who Can Participate in the Study?
- Participants in this study are postdoctoral associates and research-intensive junior faculty/new investigators who are seeking to develop a competitive NIH-style research grant proposal. Individuals who have already been awarded R01-level funding are not eligible.
- The study is ideal for researchers who are preparing their first major NIH proposal or who have submitted a previous NIH proposal that was not selected for funding. Researchers who already have been awarded a K-series award are eligible to participate in this study if they are now writing an R-series proposal.
- We are particularly interested in enrolling investigators who are preparing R-/SC-series proposals (e.g. R01, R21, R03, R15, SC1, SC2, SC3) or research career development K-series proposals (e.g. K99/R00, K01, K08, K23, etc.) in the biomedical, behavioral, clinical, and social sciences.
- For Cohort 4, participants must be targeting an NIH submission deadline of January-March, 2022 (preferred) or April-July, 2022.
Visit the study website for more information.